Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
Authors
Keywords
-
Journal
Infection and Drug Resistance
Volume Volume 15, Issue -, Pages 4127-4136
Publisher
Informa UK Limited
Online
2022-07-29
DOI
10.2147/idr.s362848
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production
- (2022) Michael Müller et al. BMC Medicine
- Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
- (2022) Jia Wei et al. NATURE MEDICINE
- Extended interval BNT162b2 vaccination enhances peak antibody generation
- (2022) Helen Parry et al. npj Vaccines
- COVID-19 vaccines: where we stand and challenges ahead
- (2021) Guido Forni et al. CELL DEATH AND DIFFERENTIATION
- B cell memory: Understanding COVID-19
- (2021) Isaak Quast et al. IMMUNITY
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine
- (2021) Tom Shimabukuro et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020
- (2021) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- COVID-19 Vaccines: Global Challenges and Prospects Forum Recommendations
- (2021) Mohamed Boudjelal et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2
- (2021) Saman Saadat et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia
- (2021) Stefania Dispinseri et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
- (2021) Florian Krammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection
- (2021) Federico Gobbi et al. Viruses-Basel
- Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots
- (2021) Jacqui Wise BMJ-British Medical Journal
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
- (2021) Joseph E. Ebinger et al. NATURE MEDICINE
- Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls
- (2021) Benedikt Simon et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
- (2021) Anton Pottegård et al. BMJ-British Medical Journal
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
- (2021) Jamie Lopez Bernal et al. BMJ-British Medical Journal
- Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
- (2021) Naif Khalaf Alharbi et al. Journal of Infection and Public Health
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021
- (2021) Megan Wallace et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- COVID-19 vaccines
- (2021) Duduzile Ndwandwe et al. CURRENT OPINION IN IMMUNOLOGY
- Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273
- (2021) Deborah Steensels et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
- (2021) Amy Flaxman et al. LANCET
- COVID‑19 vaccination and IgG and IgA antibody dynamics in healthcare workers
- (2021) Sabina Zurac et al. Molecular Medicine Reports
- Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
- (2021) Zijun Wang et al. NATURE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?
- (2021) Kenneth Lundstrom et al. Biomolecules
- Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects
- (2021) Sarah E. Wheeler et al. Microbiology Spectrum
- Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
- (2021) Rebecca P. Payne et al. CELL
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
- (2021) Gayatri Amirthalingam et al. Nature Communications
- Haematological and radiological-based prognostic markers of COVID-19
- (2021) Suliman A. Alsagaby et al. Journal of Infection and Public Health
- Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
- (2021) Mohammad Bosaeed et al. Lancet Microbe
- World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
- (2020) Catrin Sohrabi et al. International Journal of Surgery
- Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns
- (2020) Nicole Baumgarth et al. JOURNAL OF IMMUNOLOGY
- Evaluation of sample pooling for diagnosis of COVID‐19 by real time‐PCR: A resource‐saving combat strategy
- (2020) Jaya Garg et al. JOURNAL OF MEDICAL VIROLOGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
- (2020) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The Maintenance of Memory Plasma Cells
- (2019) Laleh Khodadadi et al. Frontiers in Immunology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started